Subbu Nambi
Stock Analyst at Guggenheim
(3.39)
# 996
Out of 4,734 analysts
24
Total ratings
50%
Success rate
6.64%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Reiterates: Buy | n/a | $56.88 | - | 2 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $170 → $200 | $158.36 | +26.29% | 2 | Jan 17, 2025 | |
| NEOG Neogen | Initiates: Buy | $15 | $11.56 | +29.76% | 1 | Dec 19, 2024 | |
| TEM Tempus AI | Initiates: Buy | $74 | $35.15 | +110.53% | 1 | Dec 9, 2024 | |
| GRAL GRAIL | Initiates: Neutral | n/a | $17.42 | - | 1 | Oct 17, 2024 | |
| VCYT Veracyte | Initiates: Buy | $40 | $40.58 | -1.43% | 1 | Oct 10, 2024 | |
| GH Guardant Health | Upgrades: Buy | $36 | $36.66 | -1.80% | 3 | Jun 28, 2024 | |
| SOPH SOPHiA GENETICS | Initiates: Buy | $6 | $3.12 | +92.31% | 1 | Jun 27, 2024 | |
| NAUT Nautilus Biotechnology | Initiates: Buy | $6 | $1.93 | +210.88% | 1 | Jun 27, 2024 | |
| TXG 10x Genomics | Downgrades: Neutral | n/a | $15.08 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $160.51 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $53 | $47.56 | +11.44% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $24.94 | +0.24% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $12.39 | +85.63% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $51.74 | +73.95% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.64 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $136.67 | +13.41% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.82 | - | 1 | Dec 14, 2023 |
Bruker
Jan 17, 2025
Reiterates: Buy
Price Target: n/a
Current: $56.88
Upside: -
Natera
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $158.36
Upside: +26.29%
Neogen
Dec 19, 2024
Initiates: Buy
Price Target: $15
Current: $11.56
Upside: +29.76%
Tempus AI
Dec 9, 2024
Initiates: Buy
Price Target: $74
Current: $35.15
Upside: +110.53%
GRAIL
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $17.42
Upside: -
Veracyte
Oct 10, 2024
Initiates: Buy
Price Target: $40
Current: $40.58
Upside: -1.43%
Guardant Health
Jun 28, 2024
Upgrades: Buy
Price Target: $36
Current: $36.66
Upside: -1.80%
SOPHiA GENETICS
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.12
Upside: +92.31%
Nautilus Biotechnology
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $1.93
Upside: +210.88%
10x Genomics
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $15.08
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $160.51
Upside: -
Jun 5, 2024
Initiates: Buy
Price Target: $53
Current: $47.56
Upside: +11.44%
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $24.94
Upside: +0.24%
Dec 14, 2023
Initiates: Buy
Price Target: $23
Current: $12.39
Upside: +85.63%
Dec 14, 2023
Initiates: Buy
Price Target: $90
Current: $51.74
Upside: +73.95%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.64
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $155
Current: $136.67
Upside: +13.41%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.82
Upside: -